CVS Health Corp (CVS) : Johanson Financial Advisors scooped up 249 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 14, 2016. The investment management firm now holds a total of 6,270 shares of CVS Health Corp which is valued at $556,776.CVS Health Corp makes up approximately 0.61% of Johanson Financial Advisors’s portfolio.
Other Hedge Funds, Including , Fjarde Ap-fonden Fourth Swedish National Pension Fund boosted its stake in CVS in the latest quarter, The investment management firm added 2,350 additional shares and now holds a total of 249,866 shares of CVS Health Corp which is valued at $22,188,101. CVS Health Corp makes up approx 0.49% of Fjarde Ap-fonden Fourth Swedish National Pension Fund’s portfolio.Chicago Trust Co Na boosted its stake in CVS in the latest quarter, The investment management firm added 4,934 additional shares and now holds a total of 27,827 shares of CVS Health Corp which is valued at $2,404,253. CVS Health Corp makes up approx 1.11% of Chicago Trust Co Na’s portfolio.Osborn Rohs Williams Donohoe Ltd reduced its stake in CVS by selling 3,453 shares or 3.51% in the most recent quarter. The Hedge Fund company now holds 94,831 shares of CVS which is valued at $8,193,398. CVS Health Corp makes up approx 1.60% of Osborn Rohs Williams Donohoe Ltd’s portfolio.Daiwa Sb Investments Ltd. reduced its stake in CVS by selling 2,800 shares or 28.57% in the most recent quarter. The Hedge Fund company now holds 7,000 shares of CVS which is valued at $604,800. CVS Health Corp makes up approx 0.16% of Daiwa Sb Investments Ltd.’s portfolio.
CVS Health Corp opened for trading at $88.31 and hit $88.92 on the upside on Friday, eventually ending the session at $88.8, with a gain of 0.91% or 0.8 points. The heightened volatility saw the trading volume jump to 67,05,822 shares. Company has a market cap of $94,680 M.
On the company’s financial health, CVS Health Corp reported $1.32 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.30. The company had revenue of $43725.00 million for the quarter, compared to analysts expectations of $44281.46 million. The company’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.
Investors should note that on Sep 22, 2016, CVS Health Corp announced a cash dividend of $0.4250. The company’s management has announced Oct 20, 2016 as the ex-dividend date and fixed the record date on Oct 24, 2016. The payable date has been fixed on Nov 3, 2016.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 111 from a previous price target of $108 .Company shares were Reiterated by Deutsche Bank on Aug 3, 2016 to “Hold”, Firm has raised the Price Target to $ 108 from a previous price target of $99 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.